Amgen’s first quarter 2012 revenue increased 9 percent to $4.0 billion

Amgen (NASDAQ:AMGN) reported total revenue increased 9 percent during the first quarter of 2012 to $4,048 million versus $3,706 million in the first quarter of 2011. Adjusted earnings per share (EPS)…
Read the full story: Breaking World Pharma News